AU2003241055A1 - Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis - Google Patents

Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis

Info

Publication number
AU2003241055A1
AU2003241055A1 AU2003241055A AU2003241055A AU2003241055A1 AU 2003241055 A1 AU2003241055 A1 AU 2003241055A1 AU 2003241055 A AU2003241055 A AU 2003241055A AU 2003241055 A AU2003241055 A AU 2003241055A AU 2003241055 A1 AU2003241055 A1 AU 2003241055A1
Authority
AU
Australia
Prior art keywords
determination
mycobacterium tuberculosis
disease status
surrogate markers
individual infected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003241055A
Inventor
Kenneth Duncan
Pauline Teresa LUKEY
Rohitbhai Mistry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0214251A external-priority patent/GB0214251D0/en
Priority claimed from GB0300928A external-priority patent/GB0300928D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2003241055A1 publication Critical patent/AU2003241055A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2003241055A 2002-06-20 2003-06-18 Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis Abandoned AU2003241055A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0214251A GB0214251D0 (en) 2002-06-20 2002-06-20 Surrogate markers
GB0214251.1 2002-06-20
GB0300928A GB0300928D0 (en) 2003-01-15 2003-01-15 Surrogate markers
GB0300928.9 2003-01-15
PCT/GB2003/002630 WO2004001070A1 (en) 2002-06-20 2003-06-18 Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis

Publications (1)

Publication Number Publication Date
AU2003241055A1 true AU2003241055A1 (en) 2004-01-06

Family

ID=30001966

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003241055A Abandoned AU2003241055A1 (en) 2002-06-20 2003-06-18 Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis

Country Status (2)

Country Link
AU (1) AU2003241055A1 (en)
WO (1) WO2004001070A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110129817A1 (en) * 2009-11-30 2011-06-02 Baylor Research Institute Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
NZ590341A (en) * 2008-06-25 2012-07-27 Baylor Res Inst Blood transcriptional signature of mycobacterium tuberculosis infection
WO2013138497A1 (en) * 2012-03-13 2013-09-19 Baylor Research Institute Early detection of tuberculosis treatment response
CA2867481A1 (en) 2012-04-13 2013-10-17 Somalogic, Inc. Tuberculosis biomarkers and uses thereof
GB201211158D0 (en) * 2012-06-22 2012-08-08 Univ Nottingham Trent Biomarkers and uses thereof
CN111650287B (en) * 2020-04-16 2022-10-25 广东省结核病控制中心 Small fecal peptide for detecting active tuberculosis and detection system thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020086289A1 (en) * 1999-06-15 2002-07-04 Don Straus Genomic profiling: a rapid method for testing a complex biological sample for the presence of many types of organisms
WO2002054072A2 (en) * 2001-01-08 2002-07-11 Isis Innovation Limited Assay to determine efficacy of treatment for mycobacterial infection

Also Published As

Publication number Publication date
WO2004001070A1 (en) 2003-12-31

Similar Documents

Publication Publication Date Title
AU2003287260A1 (en) Quick release assembly
AU2003263823A1 (en) Low porosity facings for acoustic applications
AU2003240952A1 (en) Walker with release mechanism
AU2003219814A1 (en) Release agents
AU2002952696A0 (en) Status determination
GB0320778D0 (en) Clutch actuator
AU2003223900A1 (en) Clutch actuating means
AU2003214438A1 (en) Providing location dependent information
AU2003268246A1 (en) Ceramic castable nanomaterials
EP1546317A4 (en) Methods of quantifying methotrexate metabolites
AU2003241055A1 (en) Surrogate markers for the determination of the disease status of an individual infected by mycobacterium tuberculosis
AU2003257167A1 (en) Electrophysiology assay methods
AU2002353625A1 (en) Electric-powered free flight plane
AU2003232598A1 (en) Clutch assembly
AUPS167602A0 (en) An improved modified release preparation
AU2003293961A1 (en) Clutch disk
AU2003242957A1 (en) Bio-degradable microspheres for diagnosing gastroesophagal reflux
AU2003288471A1 (en) Clutch accelerators
AU2003288473A1 (en) Clutch actuating systems
AU2003226562A1 (en) Anticoagulants
AU2002323816A1 (en) Term indicator
AU2003246399A1 (en) Friction clutch
AUPS034002A0 (en) Release mechanism
AU2002951582A0 (en) Combined clutch brake actuator with bias
AUPS289902A0 (en) Hook release assembly

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase